CTLA4 and neoplasm: The 200 mm3 (at start) group start treated with the anti-CTLA-4 antibody (10mg/kg, biw, ip) on day seven produced anti-tumor activity with a statistical difference (**P < 0.01) (the tumor volumes were 394±34 mm3 vs. 2,106±205 mm3).